NR ALGR
AU Supattapone,S.; Bouzamondo,E.; Ball,H.L.; Wille,H.; Nguyen,H.O.B.; Cohen,F.E.; DeArmond,S.J.; Prusiner,S.B.; Scott,M.R.D.
TI A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice
QU Molecular and Cellular Biology 2001 Apr; 21(7): 2608-16
PT journal article
AB An abridged prion protein (PrP) molecule of 106 amino acids, designated PrP106, is capable of forming infectious miniprions in transgenic mice (S. Supattapone, P. Bosque, T. Muramoto, H. Wille, C. Aagaard, D. Peretz, H.-O. B. Nguyen, C. Heinrich, M. Torchia, J. Safar, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, and M. Scott, Cell 96:869-878, 1999). We removed additional sequences from PrP106 and identified a 61-residue peptide, designated PrP61, that spontaneously adopted a protease-resistant conformation in neuroblastoma cells. Synthetic PrP61 bearing a carboxy-terminal lipid moiety polymerized into protease-resistant, beta-sheet-enriched amyloid fibrils at a physiological salt concentration. Transgenic mice expressing low levels of PrP61 died spontaneously with ataxia. Neuropathological examination revealed accumulation of protease-resistant PrP61 within neuronal dendrites and cell bodies, apparently causing apoptosis. PrP61 may be a useful model for deciphering the mechanism by which PrP molecules acquire protease resistance and become neurotoxic.
MH Animal; Mice; *Mice, Transgenic; Neurodegenerative Diseases/etiology/*genetics; Peptides/genetics; Prions/*genetics; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.
AD Institute for Neurodegenerative Diseases, University of California at San Francisco, San Francisco, California 94143, USA
SP englisch
PO USA